Schrodinger [SDGR] vs Teladoc Health [TDOC] Detailed Stock Comparison

Schrodinger Inc.

NASDAQ
Loading...

Teladoc Health Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Schrodinger Inc. wins in 3 metrics, Teladoc Health Inc. wins in 15 metrics, with 0 ties. Teladoc Health Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Schrodinger Inc. Teladoc Health Inc. Better
P/E Ratio (TTM) 44.39 N/A N/A
Price-to-Book Ratio 2.39 0.74 Teladoc Health Inc.
Debt-to-Equity Ratio 30.03 75.06 Schrodinger Inc.
PEG Ratio -8.54 -6.16 Teladoc Health Inc.
EV/EBITDA -3.63 38.86 Teladoc Health Inc.
Profit Margin (TTM) -40.36% -7.92% Teladoc Health Inc.
Operating Margin (TTM) -19.67% -4.20% Teladoc Health Inc.
Return on Equity -26.29% -13.93% Teladoc Health Inc.
Return on Assets (TTM) -13.47% -3.20% Teladoc Health Inc.
Free Cash Flow (TTM) $12.46M $137.33M Teladoc Health Inc.
1-Year Return -29.69% 9.97% Teladoc Health Inc.
Price-to-Sales Ratio (TTM) 3.40 0.41 Teladoc Health Inc.
Enterprise Value $584.24M $1.28B Teladoc Health Inc.
EV/Revenue Ratio 2.28 0.51 Teladoc Health Inc.
Gross Profit Margin (TTM) 65.68% 69.32% Teladoc Health Inc.
Revenue per Share (TTM) $3 $14 Teladoc Health Inc.
Earnings per Share (Diluted) $-1.41 $-34.20 Schrodinger Inc.
Beta (Stock Volatility) 1.62 2.08 Schrodinger Inc.
Short % of Float 26.87% 16.55% Teladoc Health Inc.

Schrodinger Inc. vs Teladoc Health Inc. Stock Performance Analysis

Loading Price Chart...

SDGR
TDOC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Schrodinger Inc.-0.07%13.61%15.81%22.96%-12.53%-16.91%
Teladoc Health Inc.-5.97%14.42%13.73%46.12%0.53%6.95%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Schrodinger Inc.-29.69%-57.36%-78.84%-52.38%-52.38%-52.38%
Teladoc Health Inc.9.97%-68.91%-94.81%-35.62%-72.82%-72.82%

Performance & Financial Health Analysis: Schrodinger Inc. vs Teladoc Health Inc.

MetricSDGRTDOC
Market Information
Market Cap i$870.40M$1.04B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,739,8004,716,750
90 Day Avg. Volume i1,277,0404,439,277
Last Close$14.93$7.09
52 Week Range$10.94 - $27.63$4.40 - $9.77
% from 52W High-45.96%-27.43%
All-Time High$117.00 (Feb 22, 2021)$308.00 (Feb 15, 2021)
% from All-Time High-87.24%-97.70%
Growth Metrics
Quarterly Revenue Growth-0.01%0.00%
Quarterly Earnings Growth-0.01%0.00%
Financial Health
Profit Margin (TTM) i-0.40%-0.08%
Operating Margin (TTM) i-0.20%-0.04%
Return on Equity (TTM) i-0.26%-0.14%
Debt to Equity (MRQ) i30.0375.06
Cash & Liquidity
Book Value per Share (MRQ)$4.94$7.77
Cash per Share (MRQ)$5.36$4.38
Operating Cash Flow (TTM) i$13.90M$294.36M
Levered Free Cash Flow (TTM) i$99.98M$226.14M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Schrodinger Inc. vs Teladoc Health Inc.

MetricSDGR (Apr 26, 2026)TDOC (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i44.39N/A
Forward P/E i-8.54-6.16
PEG Ratio i-8.54-6.16
Price to Sales (TTM) i3.400.41
Price to Book (MRQ) i2.390.74
Market Capitalization
Market Capitalization i$870.40M$1.04B
Enterprise Value i$584.24M$1.28B
Enterprise Value Metrics
Enterprise to Revenue i2.280.51
Enterprise to EBITDA i-3.6338.86
Risk & Other Metrics
Beta i1.622.08
Book Value per Share (MRQ) i$4.94$7.77

Financial Statements Comparison: Schrodinger Inc. vs Teladoc Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSDGR (2025)TDOC (2025)
Revenue/Sales i255.87M2.53B
Cost of Goods Sold i113.26M771.59M
COGS % of Revenue i44.3%30.5%
Gross Profit i142.61M1.76B
Gross Margin i55.7%69.5%
Research & Development i173.14M277.92M
Operating Income (EBIT) i-166.90M-163.40M
Operating Margin i-65.2%-6.5%
EBITDA i-209.05M260.18M
EBITDA Margin i-81.7%10.3%
Pre-Tax Income i-102.33M-235.53M
Pre-Tax Income % of Revenue i-40.0%-9.3%
Income Tax i939,000-35.21M
Income Tax % of Revenue i0.4%-1.4%
Net Income (Profit) i-103.27M-200.32M
Profit Margin i-40.4%-7.9%

Balance Sheet & Liquidity Metrics

MetricSDGR (2025)TDOC (2025)
Cash & Equivalents i230.52M781.08M
Total Current Assets i519.27M1.12B
Total Current Assets % of Revenue i202.9%44.2%
Total Current Liabilities i189.14M404.74M
Total Current Liabilities % of Revenue i73.9%16.0%
Long-Term Debt i92.82M1.03B
Long-Term Debt % of Revenue i36.3%40.7%
Total Shareholders Equity i364.05M1.39B
Retained Earnings i-628.81M-16.43B
Retained Earnings % of Revenue i-245.8%-649.4%
Property, Plant & Equipment i114.00M42.03M

Cash Flow Statement Comparison

MetricSDGR (2025)TDOC (2025)
Operating Cash Flow i69.12M225.59M
Operating Cash Flow % of Revenue i27.0%8.9%
Capital Expenditures i-1.44MN/A
Free Cash Flow i12.46M137.33M
FCF Margin i4.9%5.4%
Debt Repayment i-58,000-550.63M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSDGRTDOC
Shares Short i10.91M29.71M
Short Ratio i9.756.89
Short % of Float i26.87%16.55%
Shares Outstanding i73.68M178.32M
Float Shares i58.70M176.23M
% Held by Insiders i3.23%0.65%
% Held by Institutions i107.44%75.86%
% Held by Public i-10.67%23.49%

Dividend Analysis & Yield Comparison: Schrodinger Inc. vs Teladoc Health Inc.

MetricSDGRTDOC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A